Expressive Writing for COVID-19 Resilience
1 other identifier
interventional
63
1 country
1
Brief Summary
The purpose of this study is to determine the impact of a 6-week, virtually-delivered expressive writing intervention on resilience in a cohort of individuals currently navigating the COVID-19 pandemic during spring 2020.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2020
CompletedFirst Submitted
Initial submission to the registry
October 12, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedOctober 19, 2020
October 1, 2020
3 months
October 12, 2020
October 14, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Resilience
Connor-Davidson Resilience Scale (CD-RISC)
3 months
Secondary Outcomes (3)
Perceived stress
3 months
Depression symptoms
3 months
Post-traumatic growth
3 months
Study Arms (1)
Expressive writing
EXPERIMENTALThe expressive writing intervention consists of a 6-week, virtually-delivered writing program. Each week, participants meet for 90 minutes via Zoom and will be guided through writing prompts designed to encourage emotional expression and enhance personal resilience. The progression of writing exercises flows as follows: * Week 1: Writing to expressive difficult emotions * Week 2: Writing to release \& integrate difficult emotions * Week 3: Writing to nurture gratitude * Week 4: Writing to enhance strengths \& resources * Week 5: Writing to cultivate positive meaning \& savor goodness * Week 6: Writing to invite insight, perspective, \& growth
Interventions
The expressive writing intervention consists of a 6-week, virtually-delivered writing program. Each week, participants meet for 90 minutes via Zoom and will be guided through writing prompts designed to encourage emotional expression and enhance personal resilience. The progression of writing exercises flows as follows: * Week 1: Writing to expressive difficult emotions * Week 2: Writing to release \& integrate difficult emotions * Week 3: Writing to nurture gratitude * Week 4: Writing to enhance strengths \& resources * Week 5: Writing to cultivate positive meaning \& savor goodness * Week 6: Writing to invite insight, perspective, \& growth
Eligibility Criteria
You may qualify if:
- Potential subjects will be considered eligible if they feel they have been personally impacted by circumstances surrounding COVID-19. Other eligibility criteria include:
- Able to speak, read, write, and understand English
- Cognitively able to provide consent
- Ability to participate in a 6-week intervention delivered via Zoom, REDCap, and email
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Integrative Medicine
Durham, North Carolina, 27705, United States
Related Publications (1)
Bechard E, Evans J, Cho E, Lin Y, Kozhumam A, Jones J, Grob S, Glass O. Feasibility, acceptability, and potential effectiveness of an online expressive writing intervention for COVID-19 resilience. Complement Ther Clin Pract. 2021 Nov;45:101460. doi: 10.1016/j.ctcp.2021.101460. Epub 2021 Jul 27.
PMID: 34332289DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Oliver Glass, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2020
First Posted
October 19, 2020
Study Start
May 26, 2020
Primary Completion
August 17, 2020
Study Completion
August 17, 2020
Last Updated
October 19, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share